| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Apellis Pharmaceuticals, Inc. (APLS) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. APLS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 1.18M | $48.30M | - | |
| CEO | 482.0K | $19.78M | - | |
| Dir | 385.0K | $15.80M | - | |
| Dir | 161.6K | $6.63M | - | |
| CFO | 152.0K | $6.24M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 3, 2023 | Townsend Adam J.74 | Chief Commercial Officer | Sale+OE | 5,000 | $63.84 | $319,200.00 | -6.2% | +34.4% | -1.7% | |
| Mar 1, 2023 | Dunlop A. Sinclair62 | Director | Sell | 500 | $65.33 | $32,665.00 | -0.4% | +35.8% | -3.2% | |
| Feb 23, 2023 | Eisele Jeffrey76 | Chief Development Officer | Sell | 1,646 | $68.76 | $113,178.96 | -3.0% | +29.3% | +2.3% | |
| Feb 23, 2023 | Lewis Karen76 | Chief People Officer | Sell | 1,104 | $68.76 | $75,911.04 | -2.6% | +29.3% | +2.3% | |
| Feb 17, 2023 | MacHiels Alec57 | Director | Sale+OE | 1,250 | $52.38 | $65,475.00 | -0.5% | +57.7% | +24.0% | |
| Feb 8, 2023 | Deschatelets Pascal69 | Chief Scientific Officer | Sale+OE | 12,000 | $54.45 | $653,400.00 | -1.2% | +71.1% | +30.3% | |
| Feb 3, 2023 | Townsend Adam J.74 | Chief Commercial Officer | Sale+OE | 5,000 | $55.85 | $279,250.00 | -6.9% | +54.0% | +14.2% | |
| Feb 1, 2023 | Dunlop A. Sinclair62 | Director | Sell | 500 | $52.61 | $26,305.00 | -0.4% | +51.1% | +12.9% | |
| Jan 30, 2023 | Eisele Jeffrey76 | Chief Development Officer | Sell | 883 | $52.76 | $46,587.08 | -1.9% | +57.2% | +25.1% | |
| Jan 30, 2023 | Lewis Karen76 | Chief People Officer | Sell | 883 | $52.76 | $46,587.08 | -2.4% | +57.2% | +25.1% |